Kineta Stock (NASDAQ: KA) stock price, news, charts, stock research, profile.
Open | $0.458 |
Close | $0.486 |
Volume / Avg. | 848.743K / 324.179K |
Day Range | 0.411 - 0.550 |
52 Wk Range | 0.334 - 5.390 |
Market Cap | $5.767M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 0.79% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kineta (NASDAQ: KA) through any online brokerage.
Other companies in Kineta’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI) and Finch Therapeutics Gr (NASDAQ:FNCH).
The latest price target for Kineta (NASDAQ: KA) was reported by HC Wainwright & Co. on Thursday, January 18, 2024. The analyst firm set a price target for 8.00 expecting KA to rise to within 12 months (a possible 1420.62% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Kineta (NASDAQ: KA) is $0.5261 last updated April 18, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Kineta.
Kineta’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Kineta.
Kineta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.